Publications
Rifapentine access in Europe: growing concerns over key tuberculosis treatment component.
2022
Eur Respir J
Guglielmetti L, Günther G, Leu C et al
DOI:
10.1183/13993003.00388-2022.
Co-administration of treatment for rifampicin-resistant TB and chronic HCV infection: A TBnet and ESGMYC study.
2022
J Infect
Tunesi S, Dû DL, Gualano G, et al.
DOI:
10.1016/j.jinf.2022.03.004
Safety and Outcomes of Amikacin Liposome Inhalation Suspension for Mycobacterium abscessus Pulmonary Disease: A NTM-NET.
2022
Chest
Zweijpfenning HSM, Chiron R, Essink S, et al.
DOI:
10.1016/j.chest.2022.01.015
Meningitis Study Group. Treatment and outcome in children with tuberculous meningitis - a multi-centre Paediatric Tuberculosis Network European Trials Group study
2021
Clin Infect Dis
Thee S, Basu Roy R, Blázquez-Gamero D, et al.
DOI:
10.1093/cid/ciab982
The ability of the neonatal immune response to handle SARS-CoV-2 infection.
2021
Lancet Child Adolesc Health
Götzinger F, Santiago-Garcia B, Fumadó-Pérez V, et al.
DOI:
10.1016/S2352-4642(21)00002-X
Discovery and validation of a personalized risk predictor for incident tuberculosis in low transmission settings.
2020
Nat Med
Gupta RK, Calderwood CJ, Yavlinsky A, et al.
DOI:
10.1038/s41591-020-1076-0
Epidemiology of nontuberculous mycobacterial pulmonary disease in Europe and Japan by Delphi estimation.
2020
Respir Med
Schildkraut JA, Gallagher J, Morimoto K, et al.
DOI:
10.1016/j.rmed.2020.106164
Management of drug toxicity in M. avium complex pulmonary disease - an expert panel survey.
2020
Clin Infect Dis
van Ingen J, Aliberti S, Andrejak C, et al.
DOI:
10.1093/cid/ciaa1361
Non-tuberculous mycobacterial lung disease in patients with bronchiectasis: perceived risk, severity and guideline adherence in a European physician survey.
2020
BMJ Open Respir Res
Wagner D, van Ingen J, van der Laan R, et al.
DOI:
10.1136/bmjresp-2019-000498
COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study.
2020
Lancet Child Adolesc Health
Götzinger F, Santiago-García B, Noguera-Julián A, et al.
DOI:
10.1016/S2352-4642(20)30177-2
Multidrug-resistant tuberculosis in the Kharkiv Region, Ukraine.
2020
Int J Tuberc Lung Dis
Butov D, Lange C, Heyckendorf J, et al.
DOI:
10.5588/ijtld.19.0508
Performance of immune-based and microbiological tests in children with tuberculosis meningitis in Europe: a multicentre Paediatric Tuberculosis Network European Trials Group (ptbnet) study.
2020
Eur Respir J
Basu Roy R, Thee S, Blázquez-Gamero D, et al.
DOI:
10.1183/13993003.02004-2019
The Tuberculosis Network European Trials group (TBnet) ERS Clinical Research Collaboration: addressing drug-resistant tuberculosis through European cooperation.
2019
Eur Respir J
van Leth F, Brinkmann F, Cirillo DM, et al.
DOI:
10.1183/13993003.02089-2018
Burden and Characteristics of the Comorbidity Tuberculosis-Diabetes in Europe: TBnet Prevalence Survey and Case-Control Study.
2019
Open Forum Infect Dis
Sane Schepisi M, Navarra A, Altet Gomez MN, et al.
DOI:
10.1093/ofid/ofy337
Tuberculosis disease in children and adolescents on therapy with anti-tumor necrosis factor-alpha agents: a collaborative, multi-centre ptbnet study.
2019
Clin Infect Dis
Noguera-Julian A, Calzada-HernÁndez J, Brinkmann F, et al.
DOI:
10.1093/cid/ciz1138